if the news is correct, the US have released a statement declaring the hull or stalk is exempt from approval requirements ,while there is a great deal of focus on medicinal product approval for any with low THC might only be a matter of delivery system "pill form" not efficacy or product control just dosage if THC is incorporated, however it should be realised the whole plant can be used which puts it firmly in the spectrum of broad acre cropping as an industry from grower to processor to manufacture , marketing and then the consumer this is absolutely huge and will attract the attention of big money to develop an industry, Should QBL be able to morph as a player of scale without a T/O yes it could be enormous ----thats still a lot of ifs at this point and might well be provided with some answers with the next release, the more you evaluate the easier it is to recognise why this has been largely hidden buried in a Bauxite Company no doubt it created serious questions regarding the main business of the company , so yes exciting but still far from a foregone conclusion ----I would think an early T/O offer would come if all the pieces of the jigsaw fit together, so interesting times and never forget they are just one player private equity may also be working at similar business development which is high probability
- Forums
- ASX - By Stock
- CGB
- Folks, I predict we are about to see much more interest in the QBL/MCL connection. The MCL subsidiar
Folks, I predict we are about to see much more interest in the QBL/MCL connection. The MCL subsidiar, page-2
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online